How employers and TPAs can ease the rising cost of specialty drugs with medical rebates

As the Food and Drug Administration’s approval pipeline becomes increasingly populated by specialty drugs, it’s critical for all employers to explore medical rebate opportunities, where they can, to mitigate costs.